Novozymes
Provides biological solutions to customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives.
Launch date
Employees
Market cap
$32.5b
Enterprise valuation
$34.4b (Public information from Sep 2024)
Share price
DKK476.8 NZYM-B.CO
Company register number 10007127
Bagsværd Capital Region of Denmark (HQ)
Financials
Estimates*
DKK | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 14.0b | 15.0b | 17.6b | 17.9b | 29.4b | 31.3b | 33.5b |
% growth | (3 %) | 7 % | 17 % | 2 % | 64 % | 7 % | 7 % |
EBITDA | 4.8b | 5.2b | 6.1b | 5.8b | 10.5b | 11.7b | 12.7b |
% EBITDA margin | 34 % | 35 % | 35 % | 33 % | 36 % | 37 % | 38 % |
Profit | 2.8b | 3.1b | 3.7b | 3.0b | 3.1b | 5.2b | 6.1b |
% profit margin | 20 % | 21 % | 21 % | 17 % | 10 % | 17 % | 18 % |
EV / revenue | 7.3x | 10.3x | 5.9x | 6.1x | 7.8x | 7.3x | 6.7x |
EV / EBITDA | 21.2x | 29.6x | 17.0x | 18.7x | 21.9x | 19.6x | 17.8x |
R&D budget | 1.9b | 2.0b | 2.0b | 2.0b | - | - | - |
R&D % of revenue | 14 % | 13 % | 11 % | 11 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Corporate spinout | |
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Novozymes
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Novozymes
EditACQUISITION by The Mosaic Company Feb 2022
ACQUISITION by Novozymes Sep 2016
ACQUISITION by Novozymes Dec 2022
ACQUISITION by Novozymes Jun 2013
ACQUISITION by Novozymes Nov 2012
ACQUISITION by Novozymes Sep 2006
ACQUISITION by Novozymes Nov 2021